Muriel Duluc

713 total citations
11 papers, 225 citations indexed

About

Muriel Duluc is a scholar working on Oncology, Epidemiology and Cancer Research. According to data from OpenAlex, Muriel Duluc has authored 11 papers receiving a total of 225 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 3 papers in Epidemiology and 3 papers in Cancer Research. Recurrent topics in Muriel Duluc's work include Colorectal Cancer Treatments and Studies (6 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Neuroendocrine Tumor Research Advances (3 papers). Muriel Duluc is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Neuroendocrine Tumor Research Advances (3 papers). Muriel Duluc collaborates with scholars based in France. Muriel Duluc's co-authors include Jean‐François Seitz, Laëtitia Dahan, Joseph Ciccolini, Aurore Blesius, Bruno Lacarelle, Cédric Mercier, Sarah Giacometti, Caroline Raynal, G. Milano and Alexandre Evrard and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and British Journal of Clinical Pharmacology.

In The Last Decade

Muriel Duluc

10 papers receiving 223 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Muriel Duluc France 6 147 102 40 35 30 11 225
Shyam Aggarwal India 9 118 0.8× 37 0.4× 41 1.0× 41 1.2× 16 0.5× 38 208
Pedro Sánchez‐Godoy Spain 7 65 0.4× 99 1.0× 39 1.0× 19 0.5× 16 0.5× 18 220
Kota Yoshifuji Japan 6 53 0.4× 111 1.1× 34 0.8× 31 0.9× 17 0.6× 28 208
Ramya Muddasani United States 9 57 0.4× 121 1.2× 80 2.0× 62 1.8× 13 0.4× 32 235
A.C. Virgili Manrique Spain 10 115 0.8× 86 0.8× 24 0.6× 41 1.2× 36 1.2× 25 243
Vanesa de Luque Spain 3 255 1.7× 69 0.7× 25 0.6× 38 1.1× 17 0.6× 3 336
Sadia Abbasi United States 9 74 0.5× 91 0.9× 22 0.6× 8 0.2× 23 0.8× 13 308
Mazen Nasrallah United States 7 170 1.2× 47 0.5× 36 0.9× 41 1.2× 16 0.5× 14 290
Elizabeth Brém United States 10 112 0.8× 86 0.8× 14 0.3× 8 0.2× 37 1.2× 35 270
Omar Abdihamid United States 8 79 0.5× 74 0.7× 45 1.1× 81 2.3× 13 0.4× 27 197

Countries citing papers authored by Muriel Duluc

Since Specialization
Citations

This map shows the geographic impact of Muriel Duluc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muriel Duluc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muriel Duluc more than expected).

Fields of papers citing papers by Muriel Duluc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muriel Duluc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muriel Duluc. The network helps show where Muriel Duluc may publish in the future.

Co-authorship network of co-authors of Muriel Duluc

This figure shows the co-authorship network connecting the top 25 collaborators of Muriel Duluc. A scholar is included among the top collaborators of Muriel Duluc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muriel Duluc. Muriel Duluc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Duluc, Muriel, et al.. (2021). Impact of a Molecular Sequencing Systematic at Diagnosis in Digestive Oncology: Experience of a French Center. HAL (Le Centre pour la Communication Scientifique Directe). 1–13. 1 indexed citations
2.
Duluc, Muriel, et al.. (2019). REVIEW OF IRSN WORK REGARDING NUCLEAR CRITICALITY ACCIDENT. HAL (Le Centre pour la Communication Scientifique Directe).
3.
Aparicio, Thomas, Faïza Khemissa, Pascal Artru, et al.. (2018). Phase II trial to evaluate efficacy and tolerance of regorafenib monotherapy in patients (pts) over 70 with previously treated metastatic colorectal adenocarcinoma (mCRC) FFCD 1404 - REGOLD. Annals of Oncology. 29. viii156–viii156. 2 indexed citations
4.
Lepage, Côme, Laurent Cany, E. Maillard, et al.. (2016). Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer - PRODIGE 13 a FFCD and Unicancer phase III trial: baseline characteristics. Annals of Oncology. 27. vi159–vi159. 3 indexed citations
5.
Launay, Manon, Laëtitia Dahan, Anne Rodallec, et al.. (2015). Beating the odds: efficacy and toxicity of dihydropyrimidine dehydrogenase‐driven adaptive dosing of 5‐FU in patients with digestive cancer. British Journal of Clinical Pharmacology. 81(1). 124–130. 43 indexed citations
6.
Norguet, Emmanuelle, et al.. (2013). Severe hypersensitivity pneumonitis associated with everolimus therapy for neuroendocrine tumour: a case report. BMC Research Notes. 6(1). 471–471. 8 indexed citations
7.
Serdjebi, Cindy, Jean‐François Seitz, Joseph Ciccolini, et al.. (2013). Rapid Deaminator Status is Associated With Poor Clinical Outcome in Pancreatic Cancer Patients Treated with a Gemcitabine-Based Regimen. Pharmacogenomics. 14(9). 1047–1051. 33 indexed citations
8.
Dahan, Laëtitia, Joseph Ciccolini, Cédric Mercier, et al.. (2010). Treatment failure upon gemcitabine intake: Is cytidine deaminase extensivity the ideal culprit?. Journal of Clinical Oncology. 28(15_suppl). e14558–e14558. 1 indexed citations
9.
Ciccolini, Joseph, Laëtitia Dahan, Nicolás André, et al.. (2009). Cytidine Deaminase Residual Activity in Serum Is a Predictive Marker of Early Severe Toxicities in Adults After Gemcitabine-Based Chemotherapies. Journal of Clinical Oncology. 28(1). 160–165. 86 indexed citations
10.
Mercier, Cédric, Caroline Raynal, Laëtitia Dahan, et al.. (2007). Toxic death case in a patient undergoing gemcitabine-based chemotherapy in relation with cytidine deaminase downregulation. Pharmacogenetics and Genomics. 17(10). 841–844. 43 indexed citations
11.
Dahan, Laëtitia, Pauline Ries, Muriel Duluc, et al.. (2007). L’anasarque : une complication du traitement par la gemcitabine chez deux malades porteurs d’un cancer du pancréas. Gastroentérologie Clinique et Biologique. 31(12). 1143–1145. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shyam Aggarwal Breakdown of academic impact, for papers by Pedro Sánchez‐Godoy Breakdown of academic impact, for papers by Kota Yoshifuji Breakdown of academic impact, for papers by Ramya Muddasani Breakdown of academic impact, for papers by A.C. Virgili Manrique Breakdown of academic impact, for papers by Vanesa de Luque Breakdown of academic impact, for papers by Sadia Abbasi Breakdown of academic impact, for papers by Mazen Nasrallah Breakdown of academic impact, for papers by Elizabeth Brém Breakdown of academic impact, for papers by Omar Abdihamid
Rankless by CCL
2026